Bluejay Diagnostics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for BJDX, updated each market day.
BJDX AI Sentiment
AI predicts Bluejay Diagnostics, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Bluejay Diagnostics, Inc. Common Stock
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Sector
Exchange
Market Cap
$1,872,834
Cap Tier
Employees
6
Headquarters
ACTON, MA
Listed Since
Nov. 10, 2021
Website
BJDX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BJDX Volatility
Bluejay Diagnostics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
